bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.235
-0.035 (-2.76%)
Nov 21, 2024, 4:00 PM EST - Market closed

bioAffinity Technologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
191413--
Market Cap Growth
174.53%4.34%---
Enterprise Value
21111--
Last Close Price
1.271.471.60--
PS Ratio
1.465.522788.17--
PB Ratio
5.042.881.21--
P/TBV Ratio
30.285.341.21--
EV/Sales Ratio
2.224.40147.57--
Debt / Equity Ratio
0.550.330.02-0.97-0.91
Asset Turnover
1.120.250.00--
Inventory Turnover
345.12144.93---
Quick Ratio
0.841.6210.030.100.01
Current Ratio
1.021.7710.500.110.01
Return on Equity (ROE)
-167.00%-99.84%---
Return on Assets (ROA)
-62.34%-48.85%-36.77%-172.53%-
Return on Capital (ROIC)
-77.19%-56.22%-45.94%--
Earnings Yield
-42.67%-56.80%-60.89%--
FCF Yield
-43.37%-32.04%--
Buyback Yield / Dilution
-26.38%-94.43%-68.17%-0.02%-
Total Shareholder Return
-26.38%-94.43%-68.17%-0.02%-
Source: S&P Capital IQ. Standard template. Financial Sources.